Comprehensive Master Guide to MK 2866 (S22, Ostarine or Enobosarm): Molecular Architecture, Tissue Selectivity, and Wholesale Supply

In the sophisticated landscape of advanced biochemical research, endocrinology studies, and cutting-edge pharmaceutical development, Selective Androgen Receptor Modulators (SARMs) have fundamentally transformed the paradigm of non-steroidal ligand design. Traditional anabolic-androgenic agents have long presented researchers with a significant pharmacological paradox: while they successfully promote skeletal muscle hypertrophy, nitrogen retention, and osteogenic activity, their lack of tissue specificity frequently induces undesirable off-target systemic side effects, particularly in prostate, cardiovascular, and sebaceous tissues.

To overcome these structural limitations, modern medicinal chemistry engineered a new class of non-steroidal ligands designed to selectively activate androgen receptors in targeted tissues while sparing others. Among this elite group of experimental molecules, MK 2866 (S22, Ostarine or Enobosarm) stands out as the archetypal SARM, serving as the most extensively studied, clinically evaluated, and structurally refined benchmark in modern scientific literature.

At Wholesale China Peptides, we pride ourselves on being a premier global supplier of certified research compounds, raw materials, and professional-grade specialized solutions. Whether your laboratory is engaged in advanced chromatographic analysis, endocrine receptor binding assays, or large-scale B2B distribution, understanding the structural science, precise composition, pharmacokinetic profile, and synthesis standards of MK 2866 (S22, Ostarine or Enobosarm) is essential for maintaining absolute experimental accuracy.

In this comprehensive, exhaustive technical guide, we will dive deep into the molecular architecture, chemical properties, pharmacodynamics, clinical history, physical traits, formulation standards, and wholesale availability of MK 2866 (S22, Ostarine or Enobosarm).

---

1. What is MK 2866 (S22, Ostarine or Enobosarm)?

MK 2866 (S22, Ostarine or Enobosarm) is an orally active, non-steroidal Selective Androgen Receptor Modulator originally discovered and developed by GTx, Inc. (under the developmental code GTX-024 and clinical designation Enobosarm). It was engineered specifically to address muscle wasting and functional decline associated with cancer cachexia, acute and chronic muscle-wasting diseases, and age-related sarcopenia.

To fully appreciate the significance of MK 2866 (S22, Ostarine or Enobosarm) in laboratory research, one must understand its developmental position within the history of SARM pharmacology. As the most widely evaluated SARM in human clinical trials (spanning Phase I, Phase II, and Phase III trials involving hundreds of subjects), MK 2866 (S22, Ostarine or Enobosarm) established the baseline structural and pharmacokinetic principles that govern modern tissue-selective drug design.

Unlike conventional testosterone replacement therapies and synthetic anabolic steroids that stimulate androgen receptors uniformly across every tissue type in the body, MK 2866 (S22, Ostarine or Enobosarm) was engineered specifically to decouple these systemic effects—exhibiting high anabolic activity in skeletal muscle and bone tissue while demonstrating a significantly reduced stimulation profile in reproductive and secondary tissues.

Because of its unique non-steroidal chemical scaffold, MK 2866 (S22, Ostarine or Enobosarm) does not share the classic four-ring cyclopentanoperhydrophenanthrene structure of traditional steroidal hormones. Yet, it achieves an extraordinarily high binding affinity and excellent oral bioavailability, making it the undisputed gold standard subject of study in myogenesis, body composition modeling, and targeted receptor pharmacology.

---

2. Comprehensive Chemical Information and Composition

Formulating a stable, high-purity batch of MK 2866 (S22, Ostarine or Enobosarm) requires absolute precision in organic synthesis, stereochemical control, and analytical verification. Whether supplied as raw crystalline powder or prepared as a standardized research solution, understanding its exact chemical identity is paramount for laboratory quality control.

Molecular and Chemical Specifications:

• International Nonproprietary Name / Research Identifiers: Enobosarm, MK-2866, S-22, GTX-024
• IUPAC Chemical Name: (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
• Base Chemical Formula: C19H14F3N3O3C19​H14​F3​N3​O3​
• Molecular Weight: 389.33 g/mol
• Purity Standards: Exceeding 99% verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
• Physical State: Fine crystalline powder, white to off-white in color.

Core Structural Features

The chemical architecture of MK 2866 (S22, Ostarine or Enobosarm) is characterized by an aryl propionamide core structure. Specifically, it consists of a substituted cyanophenoxy group coupled with a cyano-trifluoromethylphenyl aniline group via an optically active chiral 2-hydroxy-2-methylpropanamide linker.

This unique non-steroidal configuration was discovered through rigorous structure-activity relationship (SAR) optimization studies designed to maximize anabolic potency while eliminating the structural elements responsible for unwanted side effects.

The presence of the cyano ($CN$) and trifluoromethyl (CF3CF3​) functional groups creates strong electrostatic and hydrophobic interactions within the ligand-binding domain of the androgen receptor. Furthermore, the specific stereochemistry (the 2S configuration at the chiral center of the propanamide backbone) is vital; altering this spatial orientation to the R-enantiomer dramatically reduces the compound’s binding affinity, underscoring the necessity of high-purity synthesis and stringent stereochemical control.

---

3. Mechanism of Action: Tissue Selectivity and Receptor Dynamics

The primary scientific interest surrounding MK 2866 (S22, Ostarine or Enobosarm) lies in its precise pharmacodynamic interaction with androgen receptors across different organ systems, specifically its role as a targeted tissue agonist.

Receptor Binding and Anabolic Activation

When MK 2866 (S22, Ostarine or Enobosarm) enters systemic circulation, it crosses cellular membranes and binds specifically to androgen receptors (ARs) located in target tissues. Upon binding, the SARM undergoes conformational changes that recruit specific co-activator proteins while discouraging the recruitment of co-repressors.

This selective recruitment initiates gene transcription pathways that drive protein synthesis, nitrogen retention, and cellular hypertrophy primarily in skeletal muscle and osteogenic (bone) cells. In standard in vitro and in vivo binding assays, MK 2866 (S22, Ostarine or Enobosarm) demonstrates an exceptionally high relative binding affinity for the AR—measuring with a dissociation constant (KiKi​) of approximately 1 nM, indicating extreme binding potency that rivals endogenous androgens.

The Tissue-Selectivity Phenomenon

The hallmark characteristic of MK 2866 (S22, Ostarine or Enobosarm) is its tissue selectivity. In classical androgens, receptor activation triggers identical cascades everywhere. However, SARMs operate via coregulator protein modulation.

• Skeletal Muscle & Bone: In muscle and bone tissue, MK 2866 (S22, Ostarine or Enobosarm) acts as a full agonist, robustly stimulating anabolic pathways that lead to increased muscle mass, improved physical function, and enhanced bone mineral density.
• Prostate & Reproductive Tissues: In prostate tissue and sebaceous glands, the cofactor recruitment profile differs. MK 2866 (S22, Ostarine or Enobosarm) acts with significantly reduced intrinsic activity in these tissues compared to traditional anabolic steroids. This differential activation profile makes MK 2866 (S22, Ostarine or Enobosarm) an invaluable model for studying targeted anabolic therapy without systemic hypertrophy of the prostate or severe virilizing off-target effects.

Absence of Aromatization

Because MK 2866 (S22, Ostarine or Enobosarm) is a non-steroidal compound lacking the steroid nucleus entirely, it possesses zero chemical affinity for the aromatase enzyme. It cannot convert into estrogen under any metabolic circumstances. Consequently, experimental models utilizing MK 2866 (S22, Ostarine or Enobosarm) will never experience estrogenic side effects, providing a pristine environment for studying pure androgen receptor signaling.

---

4. Pharmacokinetics and Systemic Dynamics

Understanding the pharmacokinetic profile of MK 2866 (S22, Ostarine or Enobosarm) is essential for designing accurate experimental protocols and analytical assays.

Oral Bioavailability and Absorption

Due to its stable non-steroidal chemical scaffold, MK 2866 (S22, Ostarine or Enobosarm) exhibits exceptional oral bioavailability. It resists rapid degradation in the gastrointestinal tract and enters systemic circulation efficiently following oral ingestion. In laboratory settings, it is frequently dissolved in polar organic solvents such as DMSO, polyethylene glycol (PEG), or high-purity ethanol for liquid experimental distribution.

Plasma Half-Life and Duration of Action

The terminal elimination half-life of MK 2866 (S22, Ostarine or Enobosarm) ranges between 24 hours.

This remarkably consistent 24-hour half-life is one of its most defining operational characteristics. It ensures that a single daily administration maintains stable, uninterrupted plasma concentrations and continuous androgen receptor occupancy throughout a full diurnal cycle. This sustained pharmacokinetic plateau eliminates the volatile peaks and troughs associated with short-acting compounds, ensuring consistent analytical data across multi-week experimental timeframes.

---

5. Key Research Applications and Investigative Frameworks

In the realm of advanced biochemical and endocrinological research, MK 2866 (S22, Ostarine or Enobosarm) is investigated across a wide spectrum of physiological models:

• Myogenesis and Muscle Wasting Models: As the most clinically studied SARM, MK 2866 (S22, Ostarine or Enobosarm) is the primary reference compound for catabolic wasting models (such as cancer cachexia, burn recovery, chronic obstructive pulmonary disease (COPD) wasting, and age-related sarcopenia simulations) to study its ability to stimulate muscle protein synthesis, enhance nitrogen balance, and prevent muscle atrophy without inducing systemic toxicity.
• Osteoporosis and Bone Mineralization: Due to its robust anabolic action on osteoblasts and osteoclasts, MK 2866 (S22, Ostarine or Enobosarm) is studied extensively in bone fracture healing, osteopenia, and osteoporosis models to evaluate improvements in bone mineral density, cortical thickness, and structural integrity.
• Lipid Metabolism and Cardiovascular Biomarkers: Extensive clinical trial data on MK 2866 (S22, Ostarine or Enobosarm) has allowed researchers to closely examine its dose-dependent impact on lipid profiles—specifically tracking changes in high-density lipoproteins (HDL), low-density lipoproteins (LDL), and triglycerides during targeted anabolic administration.
• Physical Function and Functional Performance: Clinical trials have consistently focused on evaluating functional improvements in 4-stair climb tests, timed-up-and-go metrics, and lean body mass accretion, making MK 2866 (S22, Ostarine or Enobosarm) the gold standard focal point for studies involving neuromuscular performance and recovery kinetics.

---

6. Physical Properties and Quality Control Standards

For laboratory technicians, analytical chemists, and wholesale buyers, recognizing the physical characteristics and quality control benchmarks of high-purity MK 2866 (S22, Ostarine or Enobosarm) is critical for experimental validation:

• Appearance: A fine, white to off-white crystalline powder (when supplied as raw API) or a clear, homogenous solution (when compounded into research liquids). It should be entirely free from discoloration, clumping, or foreign particulate matter.
• Solubility: Insoluble in water; highly soluble in polar organic solvents such as DMSO (Dimethyl sulfoxide), Ethanol, and Polyethylene Glycol (PEG 400), making it exceptionally easy to reconstitute for laboratory assays and liquid research formulations.
• Storage Recommendations: Store dry powder in a cool, dark environment (controlled room temperature between 20°C to 25°C) protected from moisture and direct UV light. Reconstituted liquid solutions should be kept refrigerated (2°C to 8°C) to maintain long-term molecular stability.
• Analytical Verification: Every production lot of MK 2866 (S22, Ostarine or Enobosarm) supplied by Wholesale China Peptides undergoes mandatory High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to verify that molecular identity, isomeric purity, and overall purity levels exceed 99%.

---

7. Why Source MK 2866 (S22, Ostarine or Enobosarm) from Wholesale China Peptides?

Navigating the global marketplace for advanced research chemicals, raw SARMs, and specialized peptide solutions requires an uncompromising commitment to supply chain integrity. Inferior synthesis, incorrect stereochemistry (such as contaminating the 2S chiral center with the inactive R-enantiomer), or contaminated powders can compromise months of laboratory research and invalidate chromatographic data.

When you partner with Wholesale China Peptides for your MK 2866 (S22, Ostarine or Enobosarm) supply needs, you gain access to an elite tier of B2B manufacturing excellence:

• Certified Laboratory Purity: All our raw powders and formulated solutions are backed by verifiable HPLC and MS certificates of analysis, ensuring absolute precision in molecular structure, chiral purity, and overall purity exceeding 99%.
• Advanced Synthesis & Quality Assurance: Produced in state-of-the-art chemical synthesis environments utilizing strict stereochemical control (guaranteeing 100% S-enantiomer configuration), rigorous crystallization techniques, and comprehensive batch testing.
• Secure, Discrete Global Logistics: We understand the sensitive nature of international research supply chains. Our specialized packaging solutions are engineered to protect delicate compounds, maintain thermal stability, and ensure seamless customs clearance worldwide.
• Scalable Wholesale Pricing: Whether you are an independent research institution, a compounding laboratory, or a large-scale distributor, our direct-to-consumer B2B pricing structures offer unmatched economic value without ever compromising on quality.

---

8. Frequently Asked Questions (FAQs)

1. What makes MK 2866 (S22, Ostarine or Enobosarm) the most famous SARM in research?

MK 2866 (S22, Ostarine or Enobosarm) is the most extensively studied SARM in human clinical trials, having completed multiple Phase II and Phase III trials sponsored by GTx, Inc. Its extensive clinical dataset provides researchers with the most robust safety, pharmacokinetic, and pharmacodynamic reference baseline in the entire SARM class.

2. Does MK 2866 (S22, Ostarine or Enobosarm) aromatize into estrogen?

No. Because MK 2866 (S22, Ostarine or Enobosarm) is a non-steroidal compound that lacks the steroid ring structure entirely, it possesses zero chemical affinity for the aromatase enzyme. It cannot convert into estrogen under any metabolic circumstances.

3. What is the active half-life of MK 2866 (S22, Ostarine or Enobosarm) in research models?

The terminal elimination half-life of MK 2866 (S22, Ostarine or Enobosarm) is precisely 24 hours. This makes it an ideal candidate for stable, once-daily administration in experimental protocols.

4. How can I place a wholesale order for MK 2866 (S22, Ostarine or Enobosarm)?

You can review our product catalog, examine batch specifications, and place secure bulk wholesale orders directly through our official platform at https://wholesalechinapeptides.com/. For specialized custom synthesis, bulk institutional pricing, or specific HPLC documentation requests, please reach out directly to our customer support and sales engineering team.

---

Conclusion

The exploration of advanced selective receptor modulators requires meticulous adherence to chemical purity, precise stereochemical control, and uncompromising manufacturing standards. MK 2866 (S22, Ostarine or Enobosarm) remains the unrivaled, essential benchmark for modern biochemical research, endocrinology studies, and myogenesis investigations where tissue-selective androgen receptor agonism is required.

Trust Wholesale China Peptides as your premier B2B partner for certified research compounds, advanced SARMs, and specialized formulations. Visit our website today to explore our comprehensive inventory, review our analytical testing reports, and secure your high-purity MK 2866 (S22, Ostarine or Enobosarm) supply.